Precipio, Inc.(PRPO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRPO Precipio, Inc.

Market Closed 11-15 16:00:00 EST

6.19

-0.25

-3.85%

High6.25	Low6.19	Vol650.00
Open6.25	D1 Closing6.44	Amplitude0.90%
Mkt Cap9.18M	Tradable Cap8.09M	Total Shares1.48M
T/O4.05K	T/O Rate0.05%	Tradable Shares1.31M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PRPO","market":"US","secType":"STK","nameCN":"Precipio, Inc.","latestPrice":6.1921,"timestamp":1731704400000,"preClose":6.44,"halted":0,"volume":650,"delay":0,"floatShares":1306096,"shares":1482133,"eps":-2.074163,"marketStatus":"Market Closed","change":-0.2479,"latestTime":"11-15 16:00:00 EST","open":6.25,"high":6.25,"low":6.1921,"amount":4052.427678,"amplitude":0.008991,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.074163,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731920400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":6.44,"volumeRatio":0.22842283625326243,"impliedVol":2.251,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PRPO/wiki","defaultTab":"wiki","newsList":[{"id":"2482426441","title":"Precipio Third Quarter 2024 Earnings: US$0.42 loss per share (vs US$1.04 loss in 3Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482426441","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482426441?lang=en_us&edition=fundamental","pubTime":"2024-11-09 22:10","pubTimestamp":1731161413,"startTime":"0","endTime":"0","summary":"NasdaqCM:PRPO Earnings and Revenue History November 9th 2024. All figures shown in the chart above are for the trailing 12 month  period. Precipio shares are down 3.2% from a week ago.You should learn about the   2 warning signs  we've spotted with Precipio .","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/precipio-third-quarter-2024-earnings-141013656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRPO"],"gpt_icon":0},{"id":"2481963327","title":"Precipio Announces Q3-2024 Shareholder Update Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2481963327","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481963327?lang=en_us&edition=fundamental","pubTime":"2024-11-07 06:00","pubTimestamp":1730930400,"startTime":"0","endTime":"0","summary":"Conference Call to be held on November 18, 2024, at 5:00 PM EST. NEW HAVEN, Conn., Nov. 06, 2024  -- Specialty cancer diagnostics companyPrecipio, Inc., will be hosting its Q3-2024 corporate update call on November 18th at 5:00 PM ET. The call will provide commentary on Precipio's Q3-2024 10-Q filed today, including financial highlights and analysis of the company's core businesses.Listeners interested in submitting questions in advance should email their questions to investors@precipiodx.comand management will do its best to address those questions during the call.Except for historical information, statements about future volumes, sales, growth, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “will,” “targets,” “goals,” “p","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/e4KsHHD745uzfsIC5GQCDQ--~B/aD03MjE7dz0zNjkzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3c92640ec1a97117265330f583bd2f4b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/e4KsHHD745uzfsIC5GQCDQ--~B/aD03MjE7dz0zNjkzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3c92640ec1a97117265330f583bd2f4b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/precipio-announces-q3-2024-shareholder-220000453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","PRPO"],"gpt_icon":1},{"id":"2473731374","title":"Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping","url":"https://stock-news.laohu8.com/highlight/detail?id=2473731374","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473731374?lang=en_us&edition=fundamental","pubTime":"2024-10-08 22:00","pubTimestamp":1728396000,"startTime":"0","endTime":"0","summary":"The unique assay enables laboratories to provide clinicians with more informed treatment decisions for their patientsNEW HAVEN, Conn., Oct.  08, 2024  (GLOBE NEWSWIRE) -- Specialty cancer diagnostics ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/08/2959865/0/en/Precipio-Expands-Bloodhound-MPN-Panel-by-Adding-CALR-Mutation-Subtyping.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","PRPO"],"gpt_icon":0},{"id":"2465647493","title":"Precipio Announces Employee Stock Option Plan Repricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2465647493","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465647493?lang=en_us&edition=fundamental","pubTime":"2024-09-07 04:01","pubTimestamp":1725652906,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240906:nFWN3KO11N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","PRPO"],"gpt_icon":0},{"id":"2465269647","title":"Precipio- Repricing Stock Options Granted Prior to Year-End 2022, Representing About 58% of Total Outstanding Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2465269647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465269647?lang=en_us&edition=fundamental","pubTime":"2024-09-07 04:01","pubTimestamp":1725652906,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240906:nFWN3KO11N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPO","BK4196"],"gpt_icon":0},{"id":"2465217647","title":"Precipio Inc -  Options Granted in 2023 and in 2024 Will Remain Unaltered","url":"https://stock-news.laohu8.com/highlight/detail?id=2465217647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465217647?lang=en_us&edition=fundamental","pubTime":"2024-09-07 04:01","pubTimestamp":1725652906,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240906:nFWN3KO11N:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","PRPO"],"gpt_icon":0},{"id":"2465474846","title":"Precipio Announces Employee Stock Option Plan Repricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2465474846","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465474846?lang=en_us&edition=fundamental","pubTime":"2024-09-07 04:00","pubTimestamp":1725652800,"startTime":"0","endTime":"0","summary":"Management lays out rationale and impact to shareholders belowNEW HAVEN, Conn., Sept.  06, 2024  (GLOBE NEWSWIRE) -- Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO) announces the Comp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/06/2942338/0/en/Precipio-Announces-Employee-Stock-Option-Plan-Repricing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPO","BK4196"],"gpt_icon":0},{"id":"2465952199","title":"Zacks Initiates Coverage of Precipio With Outperform Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2465952199","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465952199?lang=en_us&edition=fundamental","pubTime":"2024-09-05 21:47","pubTimestamp":1725544020,"startTime":"0","endTime":"0","summary":"Zacks Investment Research has recently initiated coverage of Precipio, Inc. PRPO, assigning an \"Outperform\" recommendation to the company's shares. This bullish stance reflects the company's path to profitability and robust positioning within the cancer diagnostics space.Precipio, currently operating from New Haven, CT, focuses on cancer diagnostics. The company, which aims to address the incidence of cancer misdiagnoses through the development of diagnostic products and services, operates clinical laboratories in New Haven, CT, and Omaha, NE, where it provides essential blood cancer diagnostics.Precipio saw a strong sequential revenue increase of 30% in second-quarter 2024, reaching $4.4 million. This growth was fueled by the company's Pathology and Products divisions, both of which are on the cusp of achieving profitability. The Pathology division has already hit breakeven, and the Products arm is expected to follow by the end of fourth-quarter 2024, positioning the company on track ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-initiates-coverage-precipio-outperform-134700151.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRPO"],"gpt_icon":0},{"id":"2460002485","title":"Precipio GAAP EPS of -$0.83, revenue of $4.44M","url":"https://stock-news.laohu8.com/highlight/detail?id=2460002485","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460002485?lang=en_us&edition=fundamental","pubTime":"2024-08-20 22:01","pubTimestamp":1724162494,"startTime":"0","endTime":"0","summary":"Precipio press release  (NASDAQ:PRPO): Q2  GAAP EPS of -$0.83.\nRevenue of $4.44M (+25.8% Y/Y).","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4141897-precipio-gaap-eps-of--083-revenue-of-444m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4196","PRPO"],"gpt_icon":0},{"id":"2459428828","title":"Precipio Announces Q2-2024 Shareholder Update Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2459428828","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459428828?lang=en_us&edition=fundamental","pubTime":"2024-08-16 05:00","pubTimestamp":1723755600,"startTime":"0","endTime":"0","summary":"Conference Call to be held on August 19, 2024 at 5:00 PM EDTNEW HAVEN, Conn., Aug.  15, 2024  (GLOBE NEWSWIRE) -- Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), will be hosting its ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/08/15/2931275/0/en/Precipio-Announces-Q2-2024-Shareholder-Update-Call.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4196","BNTX","BK4139","BK4548","BK4551","BK4568","BK4588","BK4535","PRPO"],"gpt_icon":0},{"id":"2454873259","title":"Press Release: Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven","url":"https://stock-news.laohu8.com/highlight/detail?id=2454873259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454873259?lang=en_us&edition=fundamental","pubTime":"2024-07-25 21:00","pubTimestamp":1721912400,"startTime":"0","endTime":"0","summary":"Precipio Reports $0.3M cash generated by operations  in Q2-2024, as the company advances towards breakeven. Company's continued growth and improved cash position alleviates the need for capital raise in the foreseeable future. NEW HAVEN, Conn., July 25, 2024  -- Specialty cancer diagnostics company Precipio, Inc. , announces that its unaudited non-GAAP Cash Burn/Generated from Operations  for Q2-2024 was $0.3M of cash generated for the quarter. It is important to note that a small contributing factor to the cash increase was the incoming cash collections that were expected in Q1, but were delayed and received in Q2 due to the impact of the Change Healthcare hack, as previously described.With cash reserves of approximately $1.3M at the end of Q2-2024, and its current pipeline of business, company management remains optimistic about the prospects of reaching breakeven by year end.This press release contains \"forward-looking statements\" within the meaning of Section 27A of the Securities ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPO"],"gpt_icon":0},{"id":"2452138154","title":"Precipio Reports Q2 2024 Revenue Of $4.4M Vs $4.33M Est; Expects Pathology Division's Revenues Will Reach More Than $1.5M Per Month By Year End","url":"https://stock-news.laohu8.com/highlight/detail?id=2452138154","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452138154?lang=en_us&edition=fundamental","pubTime":"2024-07-17 21:21","pubTimestamp":1721222515,"startTime":"0","endTime":"0","summary":"Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/07/39815690/precipio-reports-q2-2024-revenue-of-4-4m-vs-4-33m-est-expects-pathology-divisions-revenues-will-rea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPO"],"gpt_icon":0},{"id":"2452815972","title":"Precipio Reports $4.4M for Q2-2024 (Unaudited) Revenues, a Leap of 30% From Q1-2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2452815972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452815972?lang=en_us&edition=fundamental","pubTime":"2024-07-17 21:00","pubTimestamp":1721221204,"startTime":"0","endTime":"0","summary":"Precipio Reports $4.4M for Q2-2024 (Unaudited) Revenues, a Leap of 30% From Q1-2024","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240717:nTUA721NN6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","PRPO"],"gpt_icon":0},{"id":"2452159047","title":"Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2452159047","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452159047?lang=en_us&edition=fundamental","pubTime":"2024-07-17 21:00","pubTimestamp":1721221200,"startTime":"0","endTime":"0","summary":"Pathology Revenues in June exceed breakeven target and continue growth trendNEW HAVEN, Conn., July  17, 2024  (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/07/17/2914596/0/en/Precipio-Reports-4-4M-for-Q2-2024-unaudited-Revenues-a-leap-of-30-from-Q1-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","PRPO"],"gpt_icon":0},{"id":"2443658725","title":"Press Release: Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2443658725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443658725?lang=en_us&edition=fundamental","pubTime":"2024-06-14 04:00","pubTimestamp":1718308800,"startTime":"0","endTime":"0","summary":"New Shareholders Meeting Date: Friday, June 21 at 9 a.m. Eastern Time. NEW HAVEN, Conn., June 13, 2024  -- Specialty diagnostics company Precipio, Inc. , today announced that the company's 2024 Annual Meeting of Shareholders  was convened and adjourned, without any business being conducted, due to lack of the required quorum.During this process, we've realized that there are quite a few shareholders who didn't know whether their shares were voted on or not.If you are not sure if your shares were voted, you should be able to see that information on your broker portal when you log in. If you can't find that information, please reach out to your broker and ask them -- it's an easy and quick phone call and they will let you know right away.You can accomplish this in one of three easy ways that will take no more than 60 seconds:. Precipio's shareholders as of close of business on the April 19, 2024 record date who have not yet voted are encouraged to vote online","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","PRPO"],"gpt_icon":0},{"id":"2443914955","title":"Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2443914955","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443914955?lang=en_us&edition=fundamental","pubTime":"2024-06-13 04:00","pubTimestamp":1718222400,"startTime":"0","endTime":"0","summary":"The cost of a rescheduled shareholder meeting could reach $100,000NEW HAVEN, Conn., June  12, 2024  (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO) i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/12/2897869/0/en/Precipio-is-requesting-Shareholders-Brokers-vote-today-to-avoid-costly-adjournment-and-rescheduling-of-Annual-Shareholders-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPO","BK4196"],"gpt_icon":0},{"id":"2442559395","title":"Precipio Provides Status Update on Current Business Matters","url":"https://stock-news.laohu8.com/highlight/detail?id=2442559395","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2442559395?lang=en_us&edition=fundamental","pubTime":"2024-06-12 21:00","pubTimestamp":1718197201,"startTime":"0","endTime":"0","summary":"Precipio Provides Status Update on Current Business Matters","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240612:nTUALFHQT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPO","BK4196"],"gpt_icon":0},{"id":"2442595285","title":"Precipio Provides Status Update on Current Business Matters","url":"https://stock-news.laohu8.com/highlight/detail?id=2442595285","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2442595285?lang=en_us&edition=fundamental","pubTime":"2024-06-12 21:00","pubTimestamp":1718197200,"startTime":"0","endTime":"0","summary":"NEW HAVEN, Conn., June  12, 2024  (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO) provides the following update to its shareholders on various busine","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/12/2897584/0/en/Precipio-Provides-Status-Update-on-Current-Business-Matters.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPO","BK4196"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.precipiodx.com","stockEarnings":[{"period":"1week","weight":0.0151},{"period":"1month","weight":-0.095},{"period":"3month","weight":0.1446},{"period":"6month","weight":-0.0156},{"period":"1year","weight":-0.1959},{"period":"ytd","weight":-0.0474}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.129037},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.110961},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.182791},{"month":4,"riseRate":0.285714,"avgChangeRate":0.203415},{"month":5,"riseRate":0.714286,"avgChangeRate":0.135831},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.039567},{"month":7,"riseRate":0.375,"avgChangeRate":0.11179},{"month":8,"riseRate":0.375,"avgChangeRate":-0.100467},{"month":9,"riseRate":0.375,"avgChangeRate":-0.065435},{"month":10,"riseRate":0.25,"avgChangeRate":-0.064033},{"month":11,"riseRate":0.125,"avgChangeRate":-0.102878},{"month":12,"riseRate":0,"avgChangeRate":-0.14778}],"exchange":"NASDAQ","name":"Precipio, Inc.","nameEN":"Precipio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Precipio, Inc.(PRPO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Precipio, Inc.(PRPO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Precipio, Inc.,PRPO,Precipio, Inc.股票,Precipio, Inc.股票老虎,Precipio, Inc.股票老虎国际,Precipio, Inc.行情,Precipio, Inc.股票行情,Precipio, Inc.股价,Precipio, Inc.股市,Precipio, Inc.股票价格,Precipio, Inc.股票交易,Precipio, Inc.股票购买,Precipio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Precipio, Inc.(PRPO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Precipio, Inc.(PRPO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction